Support line (toll-free) (844) 835-4325 | Events help (608) 828-8852

Lung Cancer Research Foundation (merged with Free to Breathe)

participant Login


In the news

  • June 05 2018

    Share |
    In the news

    In the News: New studies presented at the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) highlight the benefits newer treatments, including immunotherapy and targeted therapy, are having on patients with lung cancer.

    Read more here:

    New York Times:

    Wall Street Journal:


Leave a comment

Comment Guidelines

Basic HTML formatting permitted -
<ul>, <li>, <strong>, <em>, <a href>, <blockquote>, <code>

©2018 Lung Cancer Research Foundation | Federal Tax ID #14-1935776 | LCRF is a 501(c)(3) public charity.